Journal article
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
Endocrine-related cancer, Vol.30(8), e220206
08/2023
DOI: 10.1530/ERC-22-0206
PMCID: PMC10388681
PMID: 37184955
Abstract
High grade neuroendocrine tumors (G3 NET) and neuroendocrine carcinomas (NEC) are a rare disease entity for which there is a limited amount of prospective data available. It has also been relatively recent that a distinction has been made between G3 NET and NEC, further complicating the approach for management. Due to the overall lack of data in this space, much of the practice for treatment of these tumors is based on expect opinion. The North American Neuroendocrine Tumor Society (NANETS) is an organization composed of experts who specialize in the management of these tumors. In an effort to provide further guidance to the oncology community in regard to the management of these rare tumors, NANETS convened a panel of experts from medical oncology, surgery, interventional radiology, nuclear medicine, radiology, pathology and radiation oncology to address critical issues surrounding the management of G3 NET and NEC that would benefit from expert consensus opinion. Here we present the recommendations from this panel of neuroendocrine experts in regard to the management of high grade, extra-pulmonary neuroendocrine tumors (G3 NET) and neuroendocrine carcinomas (NEC).
Details
- Title: Subtitle
- Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
- Creators
- Jennifer R Eads - University of PennsylvaniaThorvardur R Halfdanarson - Mayo ClinicTim Asmis - University of OttawaAndrew M. Bellizzi - University of IowaEmily K Bergsland - UCSF Helen Diller Family Comprehensive Cancer CenterArvind Dasari - The University of Texas MD Anderson Cancer CenterGhassan El-Haddad - Moffitt Cancer CenterMichael Frumovittz - The University of Texas MD Anderson Cancer CenterJoshua Meyer - Fox Chase Cancer CenterErik Mittra - Oregon Health & Science UniversitySten Myrehaug - S Myrehaug, Radiation Oncology, Odette Cancer Centre, Toronto, CanadaEric Nakakura - University of California, San FranciscoNitya Raj - Memorial Sloan Kettering Cancer CenterHeloisa P Soares - University of UtahBrian Untch - Memorial Sloan Kettering Cancer CenterNamrata Vijayvergia - Fox Chase Cancer CenterJennifer A Chan - Dana-Farber Cancer Institute
- Resource Type
- Journal article
- Publication Details
- Endocrine-related cancer, Vol.30(8), e220206
- DOI
- 10.1530/ERC-22-0206
- PMID
- 37184955
- PMCID
- PMC10388681
- NLM abbreviation
- Endocr Relat Cancer
- ISSN
- 1351-0088
- eISSN
- 1479-6821
- Alternative title
- Consensus recommendations for management of high grade neuroendocrine tumors
- Language
- English
- Electronic publication date
- 05/01/2023
- Date published
- 08/2023
- Academic Unit
- Pathology
- Record Identifier
- 9984413082002771
Metrics
13 Record Views